Optiver Holding
NAUT icon

Optiver Holding’s Nautilus Biotechnolgy NAUT Stock Holding History

Optiver Holding’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75 Hold
40
– – ﹤0.01% 2653
2026
Q1 		$155 Hold
40
– – ﹤0.01% 2229
2025
Q4 		$78 Hold
40
– – ﹤0.01% 2381
2025
Q3 		$34 Buy
+40
New +$29 ﹤0.01% 2631

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Optiver Holding's NAUT Position: Q2 2026 in Review

Optiver Holding held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 40 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Optiver Holding first reported a position in NAUT in Q3 2025 and has held it in 4 quarters since. The position peaked at $155 in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Optiver Holding held 40 shares of Nautilus Biotechnolgy worth $75 as of Q2 2026.
  • Optiver Holding left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2653 holding.
  • Optiver Holding first reported a position in Nautilus Biotechnolgy in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Nautilus Biotechnolgy position peaked at $155 in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.